Concepts (87)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Anticonvulsants | 5 | 2020 | 372 | 1.700 |
Why?
|
| Epilepsy, Temporal Lobe | 2 | 2018 | 84 | 1.100 |
Why?
|
| TOR Serine-Threonine Kinases | 6 | 2019 | 428 | 0.980 |
Why?
|
| Seizures | 7 | 2022 | 875 | 0.940 |
Why?
|
| Chromones | 1 | 2019 | 22 | 0.680 |
Why?
|
| Morpholines | 1 | 2019 | 55 | 0.660 |
Why?
|
| Mycophenolic Acid | 1 | 2018 | 51 | 0.620 |
Why?
|
| Ginkgo biloba | 1 | 2017 | 13 | 0.570 |
Why?
|
| Pentylenetetrazole | 5 | 2020 | 29 | 0.560 |
Why?
|
| Carotenoids | 1 | 2016 | 75 | 0.520 |
Why?
|
| Plant Extracts | 1 | 2017 | 118 | 0.520 |
Why?
|
| Behavior, Animal | 4 | 2024 | 477 | 0.480 |
Why?
|
| Sirolimus | 1 | 2016 | 220 | 0.460 |
Why?
|
| Epilepsy | 4 | 2019 | 859 | 0.440 |
Why?
|
| Reactive Oxygen Species | 1 | 2016 | 483 | 0.440 |
Why?
|
| Cognitive Dysfunction | 1 | 2016 | 223 | 0.430 |
Why?
|
| Brain | 3 | 2024 | 2961 | 0.380 |
Why?
|
| Zebrafish | 4 | 2020 | 384 | 0.340 |
Why?
|
| Class I Phosphatidylinositol 3-Kinases | 2 | 2019 | 74 | 0.320 |
Why?
|
| Kindling, Neurologic | 2 | 2020 | 13 | 0.320 |
Why?
|
| Rats, Wistar | 3 | 2019 | 359 | 0.310 |
Why?
|
| Disease Models, Animal | 7 | 2024 | 4308 | 0.310 |
Why?
|
| Signal Transduction | 3 | 2019 | 4524 | 0.300 |
Why?
|
| Proto-Oncogene Proteins c-akt | 3 | 2019 | 492 | 0.300 |
Why?
|
| Maze Learning | 2 | 2017 | 127 | 0.270 |
Why?
|
| Lafora Disease | 1 | 2024 | 3 | 0.240 |
Why?
|
| Animals | 11 | 2024 | 33923 | 0.230 |
Why?
|
| Motor Disorders | 1 | 2022 | 5 | 0.210 |
Why?
|
| Proto-Oncogene Proteins c-fos | 2 | 2019 | 64 | 0.200 |
Why?
|
| Epilepsy, Absence | 1 | 2022 | 31 | 0.200 |
Why?
|
| Hippocampus | 2 | 2018 | 816 | 0.200 |
Why?
|
| Cerebellar Ataxia | 1 | 2022 | 65 | 0.190 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2024 | 351 | 0.190 |
Why?
|
| Disabled Persons | 1 | 2022 | 100 | 0.190 |
Why?
|
| Pilocarpine | 2 | 2019 | 14 | 0.180 |
Why?
|
| Class Ia Phosphatidylinositol 3-Kinase | 1 | 2019 | 8 | 0.170 |
Why?
|
| Coumarins | 1 | 2019 | 23 | 0.160 |
Why?
|
| alpha-Linolenic Acid | 1 | 2019 | 15 | 0.160 |
Why?
|
| Convulsants | 1 | 2019 | 21 | 0.160 |
Why?
|
| Larva | 1 | 2019 | 247 | 0.150 |
Why?
|
| Interleukin-1beta | 1 | 2018 | 160 | 0.150 |
Why?
|
| Temporal Lobe | 1 | 2018 | 116 | 0.150 |
Why?
|
| Gene Expression | 2 | 2019 | 1592 | 0.150 |
Why?
|
| Interleukin-2 | 1 | 2018 | 236 | 0.150 |
Why?
|
| Pyrroles | 1 | 2019 | 177 | 0.150 |
Why?
|
| Neurons | 2 | 2018 | 1933 | 0.150 |
Why?
|
| Ribosomal Protein S6 | 1 | 2017 | 13 | 0.140 |
Why?
|
| Lithium Chloride | 1 | 2017 | 8 | 0.140 |
Why?
|
| Ribosomal Protein S6 Kinases, 70-kDa | 1 | 2017 | 20 | 0.140 |
Why?
|
| Crocus | 1 | 2016 | 1 | 0.140 |
Why?
|
| Plant Leaves | 1 | 2017 | 43 | 0.140 |
Why?
|
| Phytotherapy | 1 | 2017 | 49 | 0.140 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2018 | 342 | 0.130 |
Why?
|
| Mice, Knockout | 1 | 2024 | 3782 | 0.130 |
Why?
|
| Superoxide Dismutase | 1 | 2016 | 141 | 0.130 |
Why?
|
| Aggression | 1 | 2017 | 226 | 0.120 |
Why?
|
| NF-kappa B | 1 | 2016 | 462 | 0.120 |
Why?
|
| RNA, Messenger | 2 | 2019 | 2833 | 0.110 |
Why?
|
| Heart Diseases | 1 | 2019 | 482 | 0.110 |
Why?
|
| Myocardium | 1 | 2019 | 983 | 0.110 |
Why?
|
| Comorbidity | 1 | 2018 | 1491 | 0.110 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2016 | 1689 | 0.100 |
Why?
|
| Cognition Disorders | 1 | 2016 | 555 | 0.100 |
Why?
|
| Rats | 1 | 2018 | 3665 | 0.100 |
Why?
|
| Male | 6 | 2024 | 59957 | 0.100 |
Why?
|
| Anxiety | 1 | 2017 | 953 | 0.090 |
Why?
|
| Depression | 1 | 2017 | 1220 | 0.080 |
Why?
|
| Severity of Illness Index | 1 | 2016 | 2846 | 0.080 |
Why?
|
| Mice | 3 | 2024 | 17647 | 0.080 |
Why?
|
| Protein Tyrosine Phosphatases, Non-Receptor | 1 | 2024 | 18 | 0.060 |
Why?
|
| Inclusion Bodies | 1 | 2024 | 48 | 0.060 |
Why?
|
| Ataxia | 1 | 2022 | 168 | 0.050 |
Why?
|
| Swimming | 1 | 2019 | 21 | 0.040 |
Why?
|
| Lithium Compounds | 1 | 2019 | 14 | 0.040 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2019 | 151 | 0.040 |
Why?
|
| Molecular Docking Simulation | 1 | 2019 | 113 | 0.040 |
Why?
|
| Docosahexaenoic Acids | 1 | 2019 | 66 | 0.040 |
Why?
|
| Zebrafish Proteins | 1 | 2019 | 105 | 0.040 |
Why?
|
| Random Allocation | 1 | 2019 | 417 | 0.040 |
Why?
|
| Fibrosis | 1 | 2019 | 429 | 0.030 |
Why?
|
| Up-Regulation | 1 | 2019 | 874 | 0.030 |
Why?
|
| Mice, Inbred C57BL | 1 | 2024 | 4392 | 0.030 |
Why?
|
| Dietary Supplements | 1 | 2019 | 462 | 0.030 |
Why?
|
| Gene Expression Profiling | 1 | 2019 | 1680 | 0.030 |
Why?
|
| Humans | 3 | 2022 | 122971 | 0.020 |
Why?
|
| Gene Expression Regulation | 1 | 2019 | 2541 | 0.020 |
Why?
|
| Female | 1 | 2019 | 65361 | 0.010 |
Why?
|